Compliance aid labeling for medication containers
The present application is directed to patient compliance aids for a medicine container. A base label may be adhered to the medication container, and one or more indicia disposed on the base label. A top label may cover at least a portion of the base label.
Latest SpinLabel Technologies, Inc. Patents:
- Interactive Rotating Label and Closure Coordination System
- Interactive rotating label and closure coordination system
- Label measurement system for a container
- Product label wristband, method of making, and product container incorporating same
- Interactive rotating label and closure coordination system
The present application claims priority to provisional U.S. patent application Ser. No. 61/511,817, filed on Jul. 26, 2011, titled “Reminder Packaging for Improving Adherence for Self-Administered Medications,” which is hereby incorporated by reference in its entirety.
FIELD OF THE INVENTIONThe present application is directed generally to labels, and more specifically to medication container labels that function as a compliance aid for proper usage of the medicine.
BACKGROUNDMore than three billion prescriptions are written each year in the United States, and an estimated $18 billion is spent on over-the-counter medications. Both prescription and over-the-counter medications are intended to be consumed by a patient according to specific instructions for dosage and frequency. Non-compliance with these instructions has been identified as a major obstacle to the effective delivery of health care. Compliance typically means consuming the correct dosage at the correct frequency as specified in the prescription or on the over-the-counter medication packaging. According to the World Health Organization, only about half of patients with chronic diseases living in developed countries comply with their medication instructions. The reasons for non-compliance are varied, ranging from simple forgetfulness, to confusion, to ambivalence. However, the effects of non-compliance are staggering, resulting in an estimated $290 billion dollars per year in avoidable medical expenses. Additionally, studies have shown that non-compliance results in about 125,000 deaths annually in the United States, and leads to 10-25 percent of hospital and nursing home admissions.
SUMMARYThe present application is directed to patient compliance aids for a medication container and methods for patient compliance with a regimen for administration of medication. An exemplary patient compliance aid may comprise a base label adhered to a medication container, and day of week indicia disposed on the base label. A time of day indicia may be associated with the day of week indicia and may also be disposed on the base label. The patient compliance aid may further comprise a top label covering at least a portion of the base label.
According to additional exemplary embodiments, the present application may be directed to methods for patient compliance with a regimen for administration of medication from a medication container. An exemplary method may comprise adhering a base label to the medication container, and displaying an indicator on the base label. The indicator may include a symbol or character representing that medication remains in the medication container. A receiving mechanism may be associated with the indicator. The receiving mechanism may be adapted to receive an entry when the medication is removed from the medication container and consumed by the patient. At least a portion of the base label may be covered with a top label.
The present application is directed to patient compliance aids for a medication container and methods for patient compliance with a regimen for administration of medication. An exemplary patient compliance aid may comprise a base label adhered to a medication container, and day of week indicia disposed on the base label. A time of day indicia may be associated with the day of week indicia and may also be disposed on the base label. The patient compliance aid may further comprise a top label covering at least a portion of the base label.
As used herein, the leading edge refers to the first edge to be affixed to the object and the trailing edge refers to the second edge to be affixed to the object or the overlapping leading edge. Depending on the orientation of the label and the object when the label is affixed to the object, either edge of the label may be the leading edge. The orientations presented in the figures are for convenience and are not intended to be limiting in any way.
Various embodiments of a back surface 402 of the top label 300 are illustrated in
The base label adhesive 202, 204 and the top label adhesive 404, 406 may be applied in a variety of patterns as can be appreciated by one skilled in the art. The adhesive 202, 204, 404, 406 may be applied in strips, dots, droplets, circles, rectangles, squares, triangles, lines, and the like, as well as combinations of patterns.
A length of the top label 300 may be selected to be slightly longer than a circumference of the object on which it is placed, such that the top label trailing edge 304 overlaps the top label leading edge 302, and the top label trailing edge 304 is affixed to the top label leading edge 302. In various embodiments, the length of the top label 300 may be selected to be approximately the same as the circumference of the object on which it is placed, such that both the leading edge 302 and the trailing edge 304 do not overlap and are affixed to the base label front surface 108.
In various embodiments, the top label 300 may be rotatable about the base label 100, as discussed below. In these embodiments, the upper label panel 508 and lower label panel 510 may function to restrict upward and downward movement of the top label 300 in relation to the container 500, such that the top label 300 generally remains in a position covering at least a portion of the base label 100.
In various embodiments, as illustrated in
In various embodiments, the base label adhesive strips 202, 204 may comprise a permanent adhesive. In general, a permanent adhesive is one that does not readily release from a surface to which it adheres after the adhesive dries or cures. Using the base label 100 as an example, the permanent adhesive 202, 204 will tend not to release from the recessed surface 512, nor will it tend to release the base label leading edge 102 or trailing edge 104 once dried or cured. In order to remove the base label from the recessed surface 512, the base label 100 may have to be torn from the adhesive, or the adhesive strips 202, 204 may have to be fractured, which may leave some of the adhesive on the recessed surface 512 and some of the adhesive on the base label leading edge 102 or trailing edge 104. Once the surfaces affixed with the permanent adhesive are separated, they may not be reattached.
In
One of at least three types of adhesive may be used for the top label leading edge adhesive 404. A first type of adhesive is the permanent adhesive as described above for the base label 100. When a permanent adhesive is used for the top label leading edge adhesive 404, the top label leading edge 302 generally cannot be detached without inflicting damage to one or both of the top label 300 or the base label 100. This may be desirable for various embodiments where the top label 300 is not intended to be removed from the container 500.
A second type of adhesive that may be used for the top label leading edge adhesive 404 is a releasable adhesive. A releasable adhesive is one that will release from a surface to which it is attached once a sufficient mechanical force is applied. A releasable adhesive may be used, for example, when the top label back surface 402 comprises a coupon for a subsequent purchase of a product. The releasable adhesive may allow the consumer to easily remove the top label 300 for later use. In various embodiments, the releasable adhesive may be a breakaway adhesive. A breakaway adhesive may have limited ability to withstand shear stresses. Shear stresses may cause the adhesive bond created between the label (e.g., top label 300) and the surface to which it is affixed (e.g., the base label 100 or container 500) to fail along the adhesive. In general, a releasable or breakaway adhesive may not re-attach to a surface once removed.
A third type of adhesive that may be used for the top label leading edge adhesive 404 is a resealable adhesive. A resealable adhesive may release from a surface to which it is attached once a sufficient mechanical force is applied, similar to the releasable adhesive described above. However, the resealable adhesive may be re-attached to a surface by applying pressure. A resealable adhesive may be desirable when the top label back surface 402 or the base label front surface 108 comprise information that may be needed only on occasion. Thus, the consumer or user may detach the top label 300 when the information is needed, then re-attach the top label 300.
In various embodiments, the top label trailing edge adhesive 406 may be a releasable adhesive or a resealable adhesive, depending on the intended use of the top label 300. As described above, if the surfaces 108, 402 comprise information that is intended to stay with the container, the top label trailing edge adhesive 406 may be a resealable adhesive. In contrast, if the top label 300 is intended to be removed from the container 500, a releasable adhesive may be desirable.
Once the top label 300 is in position on the container 1000 as illustrated in
One skilled in the art will readily recognize that labels may be applied to containers using a variety of methods and that there may be a variety of single-label and multi-label systems other than those described above. Any such application methods or label systems may be used with the present disclosure. The above descriptions are exemplary and not to be construed as limiting in any way. Examples of other application methods and label systems may be disclosed in U.S. Pat. Nos. 5,884,421, 6,086,697, 6,237,269, 6,402,872, 6,631,578, 6,649,007, 7,087,298, and 7,172,668.
Various embodiments of the present invention may comprise a patient compliance aid that may be used, for example, on a medication container 1501. The patient compliance aid may comprise the base label 100 and the top label 300. The base label 100 may contain indicia 106 selected to correspond to a prescribed number of days and frequency per day the medication should be consumed.
In various embodiments, the base label indicia 106 may comprise time of day indicia 1210, either in conjunction with the day of week indicia 1205 as illustrated in
The day of week indicia 1205 and the time of day indicia 1210 may be placed along both a top edge and a bottom edge opposite the top edge of the base label as illustrated in
One skilled in the art will recognize that any number of symbols may comprise the time of day indicia 1210. For example,
Returning to
The patient compliance aid may further comprise top label 300 according to various embodiments. Top label 300 may comprise indicia 308 relaying medication-related information, patient-related information, medical-provider related information, and the like. Additionally, the top label may comprise a legend 1220 identifying the time of day indicia 1210, and reminder indicia 1225, which may be used to indicate the next time of day for consumption of the medication as described further below.
The top label 300 may have a height H2 and base label 100 may have a height H1 as illustrated in
In
The day of week indicia 1205 and the time of day indicia 1210 may be markable with a writing instrument, such as a pen or pencil.
As illustrated in
As discussed previously, the top label 300 may comprise a transparent window 1002 to allow writing 106 (other than the day of week indicia 1205 or the time of day indicia 1210) on the base label 100 to be visible when the top label 300 is in place.
The indicators 1901 may comprise a receiving mechanism associated with the indicators 1901, the receiving mechanism capable of receiving an entry when medication is removed from the medication container 1501. Similar to the indicia 1205, 1210 described previously, the receiving mechanism may comprise a markable surface capable of receiving a mark from a writing instrument such as a pen or pencil, or a scratchable surface. Each time medication is removed from the medication container 1501, one of the symbols or characters comprising the indicator 1901 may be marked or scratched.
In various embodiments, the day of week indicia 1205, time of day indicia 1210, writing 106, and indicator 1901 may be imprinted, embossed, or molded directly on the medication container in place of all or a portion of the base label 100.
Spatially relative terms such as “under”, “below”, “lower”, “over”, “upper”, and the like, are used for ease of description to explain the positioning of one element relative to a second element. These terms are intended to encompass different orientations of the device in addition to different orientations than those depicted in the figures. Further, terms such as “first”, “second”, and the like, are also used to describe various elements, regions, sections, etc. and are also not intended to be limiting. Like terms refer to like elements throughout the description.
As used herein, the terms “having”, “containing”, “including”, “comprising”, and the like are open ended terms that indicate the presence of stated elements or features, but do not preclude additional elements or features. The articles “a”, “an” and “the” are intended to include the plural as well as the singular, unless the context clearly indicates otherwise.
The present invention may be carried out in other specific ways than those herein set forth without departing from the scope and essential characteristics of the invention. The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive, and all changes coming within the meaning and equivalency range of the appended claims are intended to be embraced therein.
Claims
1. A patient compliance aid for a medication container, the patient compliance aid comprising:
- a base label adhered to the medication container;
- an indicator on the base label, the indicator displaying a symbol or a character;
- a receiving mechanism associated with the indicator, the receiving mechanism receiving an entry when medication is removed from the medication container; and
- a top label covering at least a portion of the base label, the top label having a dual ply construction with a vertical height less than a corresponding vertical height of the base label, the top label configured for rotating around a circumference of the base label and the top label configured for sliding in a vertical dimension over the base label, with the sliding without the rotating resulting in exposure of a previously covered segment of the portion of the base label.
2. The patient compliance aid of claim 1, the patient compliance aid further comprising:
- a time indicator associated with the indicator on the base label, the time indicator representing a time.
3. The patient compliance aid of claim 2, wherein the time is a time for medication to be removed from the container.
4. The patient compliance aid of claim 2, wherein the time is a time for medication to be administered to a patient.
5. The patient compliance aid of claim 1, wherein the indicator indicates a presence of the medication within the container.
6. The patient compliance aid of claim 1, wherein the indicator indicates a quantity of the medication within the container.
7. The patient compliance aid of claim 1, wherein the indicator indicates a quantity of medication removed from the container.
8. The patient compliance aid of claim 1, wherein the indicator indicates a quantity of the medication within the container to be administered to a patient.
9. The patient compliance aid of claim 1, wherein the indicator indicates a quantity of medication removed from the container and administered to a patient.
10. The patient compliance aid of claim 1, wherein the receiving mechanism also receives an entry when the medication is administered to a patient.
11. A method for patient compliance with a regimen for administration of medication from a medication container, the method comprising:
- adhering a base label to the medication container;
- displaying an indicator on the base label, the indicator including a symbol or a character representing that medication remains in the medication container;
- associating a receiving mechanism with the indicator, the receiving mechanism receiving an entry when the medication is removed from the medication container and administered to the patient; and
- covering at least a portion of the base label with a top label, the top label having a dual ply construction with a vertical height less than a corresponding vertical height of the base label, the top label configured for rotating around a circumference of the base label and the top label configured for sliding in a vertical dimension over the base label, with the sliding without the rotating resulting in exposure of a previously covered segment of the portion of the base label.
12. The method of claim 11, the method further comprising: associating a time indicator with the indicator on the base label, the time indicator representing a time when the medication should be taken by the patient.
13. A compliance aid for a medication container, the compliance aid comprising:
- a base label adhered to the medication container;
- a day of week indicia on the base label;
- a time of day indicia associated with the day of week indicia on the base label; and
- a top label covering at least a portion of the base label, the top label having a dual ply construction with a vertical height less than a corresponding vertical height of the base label, the top label configured for rotating around a circumference of the base label and the top label configured for sliding in a vertical dimension over the base label, with the sliding without the rotating resulting in exposure of a previously covered segment of the portion of the base label.
14. The compliance aid for the medication container of claim 13, wherein the day of week indicia is markable with a pen or pencil.
15. The compliance aid for the medication container of claim 13, wherein the day of week indicia further comprises a scratchable substance.
16. The compliance aid for the medication container of claim 13, wherein the time of day indicia is markable with a pen or pencil.
17. The compliance aid for the medication container of claim 13, wherein the time of day indicia further comprises a scratchable substance.
18. The compliance aid for the medication container of claim 13, wherein the time of day indicia has a shape corresponding to a specific time of day.
19. The compliance aid for the medication container of claim 13, the top label further comprising:
- a reminder indicia printed on the top label.
20. The compliance aid for the medication container of claim 19, wherein the reminder indicia rotates to correspond to the day of week indicia.
21. The compliance aid for the medication container of claim 19, wherein the reminder indicia rotates to correspond to the time of day indicia.
22. The compliance aid for the medication container of claim 13, the top label further comprising:
- a transparent window within a portion of the top label.
23. The compliance aid for the medication container of claim 13, wherein the top label slides over the base label.
24. The compliance aid for the medication container of claim 13, wherein the top label rotates over the base label.
25. The compliance aid for the medication container of claim 13, wherein the top label further comprises:
- a legend identifying the time of day indicia.
26. The compliance aid for the medication container of claim 13, wherein the top label further comprises:
- any of medication-related information, patient-related information or medical-provider related information.
27. The compliance aid for the medication container of claim 13, wherein the medication container is a bottle.
28. The compliance aid for the medication container of claim 13, wherein the top label slides over the day of week indicia.
29. The compliance aid for the medication container of claim 13, wherein the top label slides over the time of day indicia.
30. The compliance aid for the medication container of claim 13, wherein the base label further comprises:
- a second day of week indicia on the base label, the second day of week indicia located on an end opposite the day of week indicia.
31. The compliance aid for the medication container of claim 13, wherein the base label further comprises:
- a second time of day indicia on the base label, the second time of day indicia located on an end opposite the time of day indicia.
32. The compliance aid for the medication container of claim 31, wherein the top label covers one indicia and not the second indicia.
332208 | December 1885 | Noel |
736035 | August 1903 | Stevenson |
1054826 | March 1913 | Cole |
1064576 | June 1913 | Washburn |
1145367 | July 1915 | Herter |
1312611 | August 1919 | Chess |
1317660 | September 1919 | Carlson |
1334031 | March 1920 | Hahn |
1387625 | August 1921 | Stein |
1486313 | March 1924 | Van Antwerp |
2013616 | September 1935 | Rettenmeyer |
2069609 | February 1937 | Hanson |
2129364 | September 1938 | Simons et al. |
2441607 | May 1948 | Walls |
2468000 | April 1949 | Taylor |
2487274 | November 1949 | Schaffer |
2504076 | April 1950 | Lindblom |
2706464 | April 1955 | North |
2738564 | March 1956 | Guianne |
2739564 | March 1956 | North |
2844893 | July 1958 | Keller |
2860431 | November 1958 | Barnum |
2931657 | April 1960 | Lewis |
2935814 | May 1960 | Freeze |
2971283 | February 1961 | Parker |
3233770 | February 1966 | Waters |
3278182 | October 1966 | Lescher |
3374911 | March 1968 | White |
D210767 | April 1968 | Anglada |
3375954 | April 1968 | Honkanen et al. |
3468467 | September 1969 | Amberg |
3488880 | January 1970 | Taylor |
3523623 | August 1970 | Dorn |
3542229 | November 1970 | Beyerlein et al. |
3604584 | September 1971 | Shank |
3633781 | January 1972 | Zapata |
3733002 | May 1973 | Fujio |
3750317 | August 1973 | Morgan |
3766882 | October 1973 | Babbitt, III |
3779829 | December 1973 | Wolff |
3865671 | February 1975 | Kronsder |
3874977 | April 1975 | Pyles |
3960713 | June 1, 1976 | Carey |
4044889 | August 30, 1977 | Orentreich et al. |
4057251 | November 8, 1977 | Jones et al. |
4072553 | February 7, 1978 | Braker et al. |
4203240 | May 20, 1980 | Goodwin |
4312523 | January 26, 1982 | Haines |
4318683 | March 9, 1982 | Fishbaugh et al. |
4381615 | May 3, 1983 | Lonsmin |
4405045 | September 20, 1983 | Villa-Real |
4473429 | September 25, 1984 | Crankshaw |
4505497 | March 19, 1985 | Katzman |
4518450 | May 21, 1985 | Warmann |
4533586 | August 6, 1985 | Roule et al. |
4567681 | February 4, 1986 | Fumei |
4589943 | May 20, 1986 | Kimball et al. |
4658974 | April 21, 1987 | Fujita et al. |
4680080 | July 14, 1987 | Instance |
4700976 | October 20, 1987 | Loose |
4724973 | February 16, 1988 | Shah |
4727667 | March 1, 1988 | Ingle |
4732411 | March 22, 1988 | Siegel |
4844760 | July 4, 1989 | Dickey |
4877119 | October 31, 1989 | Hosking |
4918604 | April 17, 1990 | Baum |
4920912 | May 1, 1990 | Kirkling |
4955153 | September 11, 1990 | Albrecht et al. |
D311423 | October 16, 1990 | DeSantis |
5017261 | May 21, 1991 | Zodrow et al. |
5048870 | September 17, 1991 | Mangini et al. |
5062917 | November 5, 1991 | Zodrow |
5076613 | December 31, 1991 | Kovacs |
5078826 | January 7, 1992 | Rogall |
5116452 | May 26, 1992 | Eder |
5154448 | October 13, 1992 | Griffin et al. |
5207011 | May 4, 1993 | Coulthard |
5209367 | May 11, 1993 | Van Musscher et al. |
5215622 | June 1, 1993 | Schmelzer |
5263743 | November 23, 1993 | Jones |
5264265 | November 23, 1993 | Kaufmann |
5284363 | February 8, 1994 | Gartner et al. |
5321933 | June 21, 1994 | Seifert et al. |
5324559 | June 28, 1994 | Brombacher |
5342093 | August 30, 1994 | Weernink |
5363576 | November 15, 1994 | Piana et al. |
5370754 | December 6, 1994 | Soloman |
5403635 | April 4, 1995 | Hoffman |
5403636 | April 4, 1995 | Crum |
5405482 | April 11, 1995 | Morrissette et al. |
5462488 | October 31, 1995 | McKillip |
5484167 | January 16, 1996 | Donaldson et al. |
D368234 | March 26, 1996 | Dickinson et al. |
5525383 | June 11, 1996 | Witkowski |
5605230 | February 25, 1997 | Marino, Jr. et al. |
5605730 | February 25, 1997 | Treleaven |
5639529 | June 17, 1997 | Gozdecki et al. |
D383038 | September 2, 1997 | Willbrandt |
D386947 | December 2, 1997 | Lapierre et al. |
5712021 | January 27, 1998 | Hernandez |
5727766 | March 17, 1998 | Mayo |
5727819 | March 17, 1998 | Grosskopf et al. |
5738382 | April 14, 1998 | Grosskopf et al. |
5741381 | April 21, 1998 | Dolence et al. |
5758096 | May 26, 1998 | Barsky et al. |
5799525 | September 1, 1998 | Johnson et al. |
5800893 | September 1, 1998 | Harden |
5809674 | September 22, 1998 | Key |
5829789 | November 3, 1998 | Treleaven et al. |
5830550 | November 3, 1998 | Treleaven et al. |
5842633 | December 1, 1998 | Nurse |
5863628 | January 26, 1999 | Barry |
5883370 | March 16, 1999 | Walker et al. |
5884421 | March 23, 1999 | Key |
5953170 | September 14, 1999 | Glancy |
5975582 | November 2, 1999 | Treleaven |
6027780 | February 22, 2000 | Treleaven et al. |
6035568 | March 14, 2000 | Grosskopf et al. |
6047488 | April 11, 2000 | Tuszkiewicz |
6048423 | April 11, 2000 | Barrash et al. |
6057019 | May 2, 2000 | Barry |
D428307 | July 18, 2000 | Yeandel |
6086697 | July 11, 2000 | Key |
6120637 | September 19, 2000 | Barry |
6129802 | October 10, 2000 | Key |
6129959 | October 10, 2000 | Mercer et al. |
6158612 | December 12, 2000 | Alpert |
D436499 | January 23, 2001 | Pritchard et al. |
6212803 | April 10, 2001 | Key |
6213520 | April 10, 2001 | Treleaven et al. |
6237269 | May 29, 2001 | Key |
6253438 | July 3, 2001 | Jespersen |
6254138 | July 3, 2001 | Rawlings et al. |
6258200 | July 10, 2001 | Kassab |
6267672 | July 31, 2001 | Vance |
D446687 | August 21, 2001 | Furman et al. |
6270121 | August 7, 2001 | Dolan et al. |
6274236 | August 14, 2001 | Shacklett et al. |
6276533 | August 21, 2001 | Kaplan |
6328832 | December 11, 2001 | Otruba et al. |
6329034 | December 11, 2001 | Pendry et al. |
6360462 | March 26, 2002 | Mengel |
6385878 | May 14, 2002 | Key |
6398263 | June 4, 2002 | Treleaven et al. |
6402872 | June 11, 2002 | Key |
6413345 | July 2, 2002 | Treleaven |
D461369 | August 13, 2002 | Sims et al. |
6428639 | August 6, 2002 | Oldenburg et al. |
6431241 | August 13, 2002 | Gonzalo |
6454094 | September 24, 2002 | Salani |
6550171 | April 22, 2003 | De Werra et al. |
6550512 | April 22, 2003 | Yang |
6561246 | May 13, 2003 | Yang |
6575216 | June 10, 2003 | Yang |
6581773 | June 24, 2003 | Kaplan |
6616189 | September 9, 2003 | Raming |
6622878 | September 23, 2003 | Frey |
6631578 | October 14, 2003 | Key |
6649007 | November 18, 2003 | Key |
6669804 | December 30, 2003 | Pendry et al. |
6722568 | April 20, 2004 | Blanford et al. |
6737137 | May 18, 2004 | Franko, Sr. et al. |
6752431 | June 22, 2004 | Matthews et al. |
6755442 | June 29, 2004 | Franko, Sr. et al. |
6779480 | August 24, 2004 | Zamjahn |
6786515 | September 7, 2004 | Franko, Sr. |
6793075 | September 21, 2004 | Jeter |
6793755 | September 21, 2004 | Schaupp et al. |
6811640 | November 2, 2004 | Franko, Sr. |
6904867 | June 14, 2005 | Zamjahn |
D526847 | August 22, 2006 | Freeman |
7087298 | August 8, 2006 | Key |
D527583 | September 5, 2006 | Freeman |
D533748 | December 19, 2006 | Bresler |
7172220 | February 6, 2007 | Franko, Sr. |
7172668 | February 6, 2007 | Key |
7179514 | February 20, 2007 | Olsen et al. |
7325510 | February 5, 2008 | Giewercer |
7601410 | October 13, 2009 | Matthews et al. |
7621231 | November 24, 2009 | McNeely |
7628427 | December 8, 2009 | Adler et al. |
7782479 | August 24, 2010 | Handa et al. |
7875142 | January 25, 2011 | Matthews et al. |
7926851 | April 19, 2011 | Kaufman |
8037628 | October 18, 2011 | Kaufman |
8043993 | October 25, 2011 | Roth et al. |
D649396 | November 29, 2011 | Wilkens et al. |
8142596 | March 27, 2012 | Valenti, Jr. et al. |
8245752 | August 21, 2012 | Lingier et al. |
8272562 | September 25, 2012 | Ziegler |
8413884 | April 9, 2013 | Lim et al. |
8424761 | April 23, 2013 | Yanagi |
D682088 | May 14, 2013 | de Urquijo Carmona |
8709198 | April 29, 2014 | Key |
8727220 | May 20, 2014 | Key |
D706624 | June 10, 2014 | Key |
D706625 | June 10, 2014 | Key |
20010004152 | June 21, 2001 | Treleaven et al. |
20010017181 | August 30, 2001 | Otruba et al. |
20010025442 | October 4, 2001 | Key |
20010045741 | November 29, 2001 | Shacklett et al. |
20010050242 | December 13, 2001 | Kaplan |
20020015813 | February 7, 2002 | Pendry et al. |
20020017784 | February 14, 2002 | Merry et al. |
20020029635 | March 14, 2002 | Kremen |
20020038685 | April 4, 2002 | Key |
20020096261 | July 25, 2002 | Yang |
20020096262 | July 25, 2002 | Yang |
20020096264 | July 25, 2002 | Yang |
20020104613 | August 8, 2002 | Key |
20020130182 | September 19, 2002 | Mondie |
20020139292 | October 3, 2002 | Giewercer |
20020185212 | December 12, 2002 | Schaupp et al. |
20020193225 | December 19, 2002 | Raming |
20030006606 | January 9, 2003 | Franko, Sr. et al. |
20030012911 | January 16, 2003 | Campbell |
20030015105 | January 23, 2003 | Dewig et al. |
20030030270 | February 13, 2003 | Franko, Sr. et al. |
20030091819 | May 15, 2003 | Franko, Sr. |
20030118768 | June 26, 2003 | Sellars |
20030137145 | July 24, 2003 | Fell et al. |
20030175463 | September 18, 2003 | Olsen et al. |
20030189490 | October 9, 2003 | Hogerton et al. |
20030201064 | October 30, 2003 | Treleaven et al. |
20040108237 | June 10, 2004 | McClintock |
20040123565 | July 1, 2004 | Rice et al. |
20040166277 | August 26, 2004 | Key |
20040188998 | September 30, 2004 | Henthorn |
20040197513 | October 7, 2004 | Shacklett et al. |
20040207193 | October 21, 2004 | Franko, Sr. |
20040247863 | December 9, 2004 | Scott |
20050038558 | February 17, 2005 | Keene |
20050056203 | March 17, 2005 | Giewercer |
20050097004 | May 5, 2005 | Masse Blume |
20050181165 | August 18, 2005 | Franko, Sr. |
20050183982 | August 25, 2005 | Giewercer |
20050190914 | September 1, 2005 | Chen et al. |
20050209870 | September 22, 2005 | Alden |
20060029761 | February 9, 2006 | Matthews et al. |
20060032923 | February 16, 2006 | Krupa |
20060078701 | April 13, 2006 | Glasier |
20060145471 | July 6, 2006 | Franko, Sr. |
20060249950 | November 9, 2006 | Kenney et al. |
20070029787 | February 8, 2007 | Loftin, III et al. |
20070034103 | February 15, 2007 | Kaufman |
20070043530 | February 22, 2007 | O'Rourke |
20070119542 | May 31, 2007 | Williams et al. |
20070209753 | September 13, 2007 | Gonzalez et al. |
20070209755 | September 13, 2007 | Smith |
20070213214 | September 13, 2007 | Roth et al. |
20070221319 | September 27, 2007 | Morgan |
20070222205 | September 27, 2007 | Handa et al. |
20070252379 | November 1, 2007 | Bethune et al. |
20070299693 | December 27, 2007 | Jung et al. |
20080003391 | January 3, 2008 | Franko et al. |
20080003410 | January 3, 2008 | Shacklett et al. |
20080010874 | January 17, 2008 | Londino |
20080014344 | January 17, 2008 | Fort et al. |
20080073902 | March 27, 2008 | Franko |
20080121688 | May 29, 2008 | Harrop |
20080176955 | July 24, 2008 | Heck et al. |
20080208694 | August 28, 2008 | Baggott |
20080233405 | September 25, 2008 | Dronzek, Jr. |
20080303264 | December 11, 2008 | Kaufman |
20080303265 | December 11, 2008 | Kaufman |
20090236023 | September 24, 2009 | Lingier et al. |
20090255623 | October 15, 2009 | Bagung et al. |
20090265188 | October 22, 2009 | Lamy et al. |
20090294521 | December 3, 2009 | de la Huerga |
20100043267 | February 25, 2010 | Sterling |
20100044438 | February 25, 2010 | Chen et al. |
20100084077 | April 8, 2010 | Matthews et al. |
20100101681 | April 29, 2010 | Kramer et al. |
20100228615 | September 9, 2010 | Hays |
20100240133 | September 23, 2010 | Brivanlou et al. |
20100295916 | November 25, 2010 | Kaufman |
20100300599 | December 2, 2010 | Fort et al. |
20100307947 | December 9, 2010 | Marden et al. |
20110061802 | March 17, 2011 | Raming |
20110151115 | June 23, 2011 | Lingier |
20110169602 | July 14, 2011 | Gaffney |
20110185606 | August 4, 2011 | Londino |
20110233095 | September 29, 2011 | Seidl |
20120006712 | January 12, 2012 | Kaplan et al. |
20120010299 | January 12, 2012 | Kaplan et al. |
20120037299 | February 16, 2012 | Baeta et al. |
20120085828 | April 12, 2012 | Ziegler |
20120118503 | May 17, 2012 | Lorence et al. |
20120125526 | May 24, 2012 | Key |
20120175336 | July 12, 2012 | Miller et al. |
20120268837 | October 25, 2012 | Rittenburg et al. |
20120279632 | November 8, 2012 | Lingier et al. |
20120292219 | November 22, 2012 | Terwilliger et al. |
20130025175 | January 31, 2013 | Key |
20130025529 | January 31, 2013 | Key |
20130026747 | January 31, 2013 | Key |
20130033031 | February 7, 2013 | Key |
20130036634 | February 14, 2013 | Key |
20130036641 | February 14, 2013 | Key |
20130037619 | February 14, 2013 | Key |
20130043157 | February 21, 2013 | Key |
20130062239 | March 14, 2013 | Key |
20130129971 | May 23, 2013 | Key et al. |
20140076766 | March 20, 2014 | Key |
932891 | April 2002 | AT |
1165378 | September 2004 | AT |
723118 | November 2000 | AU |
932891 | April 2002 | BE |
1165378 | September 2004 | BE |
932891 | April 2002 | CH |
1165378 | September 2004 | CH |
69711903.3-08 | April 2002 | DE |
1165378 | September 2004 | DE |
85214 | March 1958 | DK |
932891 | April 2002 | DK |
932891 | April 2002 | EP |
1165378 | September 2004 | EP |
2742501 | June 2014 | EP |
932891 | April 2002 | ES |
965522 | September 1950 | FR |
1114750 | April 1956 | FR |
1347102 | November 1963 | FR |
2460260 | January 1981 | FR |
285514 | October 1988 | FR |
2677786 | December 1992 | FR |
932891 | April 2002 | FR |
1165378 | September 2004 | FR |
932891 | April 2002 | GB |
1039770 | May 2002 | HK |
1021056 | July 2002 | HK |
932891 | April 2002 | IE |
1E1165378 | September 2004 | IE |
327286 | July 1935 | IT |
932891 | April 2002 | IT |
204456 | September 2002 | MX |
225535 | January 2005 | MX |
227727 | May 2005 | MX |
932891 | April 2002 | NL |
334683 | November 1999 | NZ |
1565 | July 1888 | SE |
932891 | April 2002 | SE |
WO98/19289 | May 1998 | WO |
WO00/48161 | August 2000 | WO |
WO03017174 | February 2003 | WO |
WO2007020628 | February 2007 | WO |
WO2012071355 | May 2012 | WO |
WO2013015838 | January 2013 | WO |
WO2013015839 | January 2013 | WO |
WO2013016364 | January 2013 | WO |
WO2013016461 | January 2013 | WO |
WO2013019907 | February 2013 | WO |
WO2013022495 | February 2013 | WO |
WO2013022508 | February 2013 | WO |
WO2013023221 | February 2013 | WO |
WO2013025947 | February 2013 | WO |
WO2013039578 | March 2013 | WO |
WO2013043618 | March 2013 | WO |
WO2014047077 | March 2014 | WO |
- International Search Report and Written Opinion mailed May 25, 2012 in Patent Cooperation Treaty Application No. PCT/US12/22609, filed Jan. 25, 2012.
- International Search Report and Written Opinion mailed May 23, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/022610, filed Jan. 25, 2012.
- International Search Report and Written Opinion mailed Oct. 9, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/048021, filed Jul. 24, 2012.
- International Search Report and Written Opinion mailed Oct. 23, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/050643, filed Aug. 13, 2012.
- International Search Report and Written Opinion mailed Nov. 30, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/055948, filed Sep. 18, 2012.
- International Search Report and Written Opinion mailed Jul. 26, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/037395, filed May 10, 2012.
- International Search Report and Written Opinion mailed Oct. 16, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/048201, filed Jul. 25, 2012.
- International Search Report and Written Opinion mailed Jul. 9, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/031670, filed Mar. 30, 2012.
- International Search Report and Written Opinion mailed Oct. 23, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/051228, filed Aug. 16, 2012.
- International Search Report and Written Opinion mailed Oct. 16, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/049234, filed Aug. 1, 2012.
- International Search Report and Written Opinion mailed Aug. 27, 2012 in Patent Cooperation Treaty Application No. PCT/US2012/040301, filed May 31, 2012.
- Newswire, “AccuDial(R) Pharmaceutical, Inc. can put an end to underdosing and overdosing with new line of children's over-the-counter medications”, Jul. 8, 2010 [retrieved Dec. 12, 2013]. Retrieved from Internet: <http://www.newswire.ca/en/story/646945/accudial-r-pharmaceutical-inc-can-put-an-end-to-underdosing-and-overdosing-with-new-line-of-children-s-over-the-counter-medications>.
- Accudial Pharmaceutical, Inc. company website, www.accuratedose.com, Oct. 30, 2010 [retrieved Aug. 7, 2012). Retrieved from Internet: <http://web.archive.org/web/20101030115353/http://www.accuratedose.com.ca—english/home>.
- Anonymous, “Chest congestion (guaifenesin) liquid”, Internet article, http://dailymed.nlm.nih.gov/dailymed/druginfo.cfm?id=25295. (Oct. 26, 2009).
- Anonymous, “Pharmaceutical & medical packaging news”, The packaging magazine for the healthcare industry, 16: 12:76-78, Internet article, http://www.accuratedose.com/corporate/assets/pdf/PMP—MagReprinIDec08.pdf, (Dec. 12, 2008).
- A. Abramson, “Start-up has twist on safe doses for kids”, Internet article, http://www.accuratedose.com/corporate/assets/pdf/50840—ACC—PBP—Article. pdf, (Jul. 27,2009).
- Anonymous, “Chest congestion guaifenesin oral solution expectorant”, Internet article, http://accuratedose.com/us—english/producUnformation/chest—congestion.html, (Aug. 24, 2011).
- International Search Report and Written Opinion mailed Apr. 2, 2012 in Patent Cooperation Treaty Application No. PCT/US2011/061739, filed Nov. 21, 2011.
- International Search Report and Written Opinion mailed Feb. 28, 2014 in Patent Cooperation Treaty Application No. PCT/US2013/060220, filed Sep. 17, 2013.
Type: Grant
Filed: Jan 25, 2012
Date of Patent: Mar 10, 2015
Patent Publication Number: 20130026056
Assignee: SpinLabel Technologies, Inc. (Boca Raton, FL)
Inventor: Stephen M. Key (Modesto, CA)
Primary Examiner: Bryon Gehman
Application Number: 13/358,466
International Classification: G09F 11/02 (20060101); G09F 3/00 (20060101); A61J 7/04 (20060101); G09F 3/10 (20060101); G09F 3/02 (20060101);